Fortune Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 13-09-2024
- Paid Up Capital ₹ 4.00 M
as on 13-09-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.90 Cr
as on 13-09-2024
- Satisfied Charges ₹ 1.60 Cr
as on 13-09-2024
- Revenue -6.86%
(FY 2023)
- Profit -54.95%
(FY 2023)
- Ebitda 230.17%
(FY 2023)
- Net Worth 4.46%
(FY 2023)
- Total Assets -6.92%
(FY 2023)
About Fortune Pharmaceuticals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹3.90 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Mrig, Gunjankumar, and Prity Sinha serve as directors at the Company.
- CIN/LLPIN
U24230JK2006PTC002623
- Company No.
002623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2006
- Date of AGM
10 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Fortune Pharmaceuticals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Mrig  | Director | 21-Feb-2006 | Current |
| Gunjankumar | Additional Director | 18-Jul-2024 | Current |
| Prity Sinha | Additional Director | 18-Jul-2024 | Current |
Financial Performance of Fortune Pharmaceuticals India.
Fortune Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.86% decrease. The company also saw a substantial fall in profitability, with a 54.95% decrease in profit. The company's net worth moved up by a moderate rise of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortune Pharmaceuticals India?
Unlock access to Fortune Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Xenone Healthcare Private LimitedActive 12 years 9 monthsGunjankumar and Prity Sinha are mutual person
- Atlantas Worldwide Private LimitedActive 11 years 4 months
Gunjankumar and Prity Sinha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2022 | ₹1.00 Cr | Open |
Punjab National Bank Creation Date: 17 Feb 2022 | ₹5.00 M | Open |
Punjab National Bank Creation Date: 11 Nov 2021 | ₹1.00 M | Open |
How Many Employees Work at Fortune Pharmaceuticals India?
Fortune Pharmaceuticals India has a workforce of 19 employees as of Sep 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortune Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
